Suppr超能文献

头孢哌酮治疗泌尿系统和呼吸道感染的疗效与耐受性多中心研究

[Multicenter research on cefoperazone efficacy and tolerance in the therapy of urinary and respiratory infections].

作者信息

Paradisi F, de Crescenzo G, Ruffilli M P

机构信息

Università di Firenze, Istituto di Malattie Infettive.

出版信息

Minerva Med. 1989 Jan;80(1):43-51.

PMID:2644585
Abstract

In this multicenter study the authors evaluated the clinical and microbiological efficacy and the local and general safety of cefoperazone sodium in 1,546 patients (946 males and 600 females, mean age 61.3 years) with lower respiratory tract (1,044) and urinary tract (539) infections. Results were very encouraging with 95.3% of clinical cures or improvement, 91.6% of microbiological eradication, and a local and general safety which was always extremely high, i.e. 96.9% and 98.3% respectively.

摘要

在这项多中心研究中,作者评估了头孢哌酮钠对1546例(946例男性和600例女性,平均年龄61.3岁)患有下呼吸道感染(1044例)和尿路感染(539例)患者的临床和微生物学疗效以及局部和全身安全性。结果非常令人鼓舞,临床治愈率或改善率为95.3%,微生物清除率为91.6%,局部和全身安全性一直极高,分别为96.9%和98.3%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验